Karolinska Development AB (publ) (FRA:2I9)

Market Cap	9.20M
Revenue (ttm)	157.20K
Net Income (ttm)	-12.28M
Shares Out	n/a
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	496
Open	0.0146
Previous Close	0.0147
Day's Range	0.0146 - 0.0146
52-Week Range	0.0038 - 0.0850
Beta	n/a
RSI	42.76
Earnings Date	Feb 13, 2026

About Karolinska Development AB

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio com...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2003
• Employees: 8
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2I9

Financial Performance

Financial numbers in SEK